REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Contract Pharma SIA (Latvia)

Main Activities: Land Subdivision
Full name: Contract Pharma SIA Profile Updated: September 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Contract Pharma SIA is an enterprise in Latvia, with the main office in Riga. The company operates in the Land Subdivision sector. The enterprise was incorporated on October 25, 2005. There are currently 20 (2023) people employed by Contract Pharma SIA. The company’s latest financial report indicates a net sales revenue increase of 9.76% in 2025. Its’ total assets recorded a growth of 140.88%. Contract Pharma SIA’s net profit margin increased by 7.49% in 2025.

Headquarters
Kruzes iela 38
Riga; Riga; Postal Code: 1002

Contact Details: Purchase the Contract Pharma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Contract Pharma SIA report to view the information.
Registered Capital:
Purchase the Contract Pharma SIA report to view the information.
Financial Auditors:
Purchase the Contract Pharma SIA report to view the information.
Incorporation Date:
October 25, 2005
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Contract Pharma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.76%▲
Total Operating Revenue
90.32%▲
Operating Profit
N/A
Net Profit/Loss for the Period
30.56%▲
Total Assets
140.88%▲
Total Equity
29.58%▲
Operating Profit Margin
N/A
Net Profit Margin
7.49%▲
Return on Equity (ROE)
0.17%▲
Quick Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo